America’s drug price cap will focus Big Pharma on big profits. Drugmakers may now invest even more in chasing big blockbuster drugs. There are risks for both patients and shareholders, writes aimeedonnellan:
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
‘My Son Hunter’ Highlights How Bidens Ignored Uyghur Genocide to Get Rich in ChinaThe new film 'MySonHunter' depicts Hunter Biden proudly boasting of the million-dollar deals he made with China.
続きを読む »
Explainer: How the U.S. drug pricing law affects Medicare and its membersU.S. President Joe Biden last month signed the $430 billion Inflation Reduction Act, authorizing the federal government to negotiate prices on some prescription drugs and cap costs for the government's Medicare health program.
続きを読む »
BTC price clings to $20K as US stocks lose the equivalent of 4 Bitcoin market capsBTC price returns to $20,000 on a U.S. stock market rout with Bitcoin bears making a comeback.
続きを読む »
Polio is back in rich countries, but it poses a far bigger threat to developing worldWhile New York state, London and Israel have ramped up polio vaccinations in an attempt to curb their outbreaks, experts are far more concerned about paralytic polio cases in low-income countries.
続きを読む »